skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 134  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Refined by: subject: Type 2 Diabetes remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Early beta cell dysfunction vs insulin hypersecretion as the primary event in the pathogenesis of dysglycaemia
Material Type:
Article
Add to My Research

Early beta cell dysfunction vs insulin hypersecretion as the primary event in the pathogenesis of dysglycaemia

Diabetologia, 2020-10, Vol.63 (10), p.2007-2021 [Peer Reviewed Journal]

This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply 2020 ;This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply 2020. ;ISSN: 0012-186X ;ISSN: 1432-0428 ;EISSN: 1432-0428 ;DOI: 10.1007/s00125-020-05245-x ;PMID: 32894311

Full text available

2
Sodium-glucose cotransporter type 2 inhibitors for the treatment of type 2 diabetes mellitus
Material Type:
Article
Add to My Research

Sodium-glucose cotransporter type 2 inhibitors for the treatment of type 2 diabetes mellitus

Nature reviews. Endocrinology, 2020-10, Vol.16 (10), p.556-577 [Peer Reviewed Journal]

COPYRIGHT 2020 Nature Publishing Group ;Springer Nature Limited 2020. ;ISSN: 1759-5029 ;ISSN: 1759-5037 ;EISSN: 1759-5037 ;DOI: 10.1038/s41574-020-0392-2 ;PMID: 32855502

Full text available

3
Effects of SGLT2 inhibitors on systemic and tissue low-grade inflammation: The potential contribution to diabetes complications and cardiovascular disease
Material Type:
Article
Add to My Research

Effects of SGLT2 inhibitors on systemic and tissue low-grade inflammation: The potential contribution to diabetes complications and cardiovascular disease

Diabetes & metabolism, 2018-12, Vol.44 (6), p.457-464 [Peer Reviewed Journal]

2018 Elsevier Masson SAS ;Copyright © 2018 Elsevier Masson SAS. All rights reserved. ;ISSN: 1262-3636 ;ISSN: 1878-1780 ;EISSN: 1878-1780 ;DOI: 10.1016/j.diabet.2018.09.005 ;PMID: 30266577

Full text available

4
Metformin and COVID-19: From cellular mechanisms to reduced mortality
Material Type:
Article
Add to My Research

Metformin and COVID-19: From cellular mechanisms to reduced mortality

Diabetes & metabolism, 2020-11, Vol.46 (6), p.423-426 [Peer Reviewed Journal]

2020 Elsevier Masson SAS ;Copyright © 2020 Elsevier Masson SAS. All rights reserved. ;2020 Elsevier Masson SAS. All rights reserved. 2020 Elsevier Masson SAS ;ISSN: 1262-3636 ;ISSN: 1878-1780 ;EISSN: 1878-1780 ;DOI: 10.1016/j.diabet.2020.07.006 ;PMID: 32750451

Full text available

5
Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes
Material Type:
Article
Add to My Research

Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes

The New England journal of medicine, 2011-03, Vol.364 (10), p.907-917 [Peer Reviewed Journal]

Copyright © 2011 Massachusetts Medical Society. All rights reserved. ;2015 INIST-CNRS ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1007994 ;PMID: 21388309 ;CODEN: NEJMAG

Full text available

6
Effects of glucose-lowering agents on surrogate endpoints and hard clinical renal outcomes in patients with type 2 diabetes
Material Type:
Article
Add to My Research

Effects of glucose-lowering agents on surrogate endpoints and hard clinical renal outcomes in patients with type 2 diabetes

Diabetes & metabolism, 2019-04, Vol.45 (2), p.110-121 [Peer Reviewed Journal]

2018 Elsevier Masson SAS ;Copyright © 2018 Elsevier Masson SAS. All rights reserved. ;ISSN: 1262-3636 ;ISSN: 1878-1780 ;EISSN: 1878-1780 ;DOI: 10.1016/j.diabet.2018.10.003 ;PMID: 30477733

Full text available

7
Antidiabetic agents and risk of atrial fibrillation/flutter: A comparative critical analysis with a focus on differences between SGLT2 inhibitors and GLP-1 receptor agonists
Material Type:
Article
Add to My Research

Antidiabetic agents and risk of atrial fibrillation/flutter: A comparative critical analysis with a focus on differences between SGLT2 inhibitors and GLP-1 receptor agonists

Diabetes & metabolism, 2022-11, Vol.48 (6), p.101390-101390, Article 101390 [Peer Reviewed Journal]

2022 Elsevier Masson SAS ;ISSN: 1262-3636 ;ISSN: 1878-1780 ;EISSN: 1878-1780 ;DOI: 10.1016/j.diabet.2022.101390 ;PMID: 36170946

Full text available

8
Statins and clinical outcomes with COVID-19: Meta-analyses of observational studies
Material Type:
Article
Add to My Research

Statins and clinical outcomes with COVID-19: Meta-analyses of observational studies

Diabetes & metabolism, 2021-11, Vol.47 (6), p.101220-101220, Article 101220 [Peer Reviewed Journal]

2020 Elsevier Masson SAS ;Copyright © 2020 Elsevier Masson SAS. All rights reserved. ;2020 Elsevier Masson SAS. All rights reserved. 2020 Elsevier Masson SAS ;ISSN: 1262-3636 ;ISSN: 1878-1780 ;EISSN: 1878-1780 ;DOI: 10.1016/j.diabet.2020.101220 ;PMID: 33359486

Full text available

9
Reduction in HbA1c with SGLT2 inhibitors vs. DPP-4 inhibitors as add-ons to metformin monotherapy according to baseline HbA1c: A systematic review of randomized controlled trials
Material Type:
Article
Add to My Research

Reduction in HbA1c with SGLT2 inhibitors vs. DPP-4 inhibitors as add-ons to metformin monotherapy according to baseline HbA1c: A systematic review of randomized controlled trials

Diabetes & metabolism, 2020-06, Vol.46 (3), p.186-196 [Peer Reviewed Journal]

2020 Elsevier Masson SAS ;Copyright © 2020 Elsevier Masson SAS. All rights reserved. ;ISSN: 1262-3636 ;ISSN: 1878-1780 ;EISSN: 1878-1780 ;DOI: 10.1016/j.diabet.2020.01.002 ;PMID: 32007623

Full text available

10
Neprilysin inhibition: a new therapeutic option for type 2 diabetes?
Material Type:
Article
Add to My Research

Neprilysin inhibition: a new therapeutic option for type 2 diabetes?

Diabetologia, 2019-07, Vol.62 (7), p.1113-1122 [Peer Reviewed Journal]

Springer-Verlag GmbH Germany, part of Springer Nature 2019 ;Diabetologia is a copyright of Springer, (2019). All Rights Reserved. ;ISSN: 0012-186X ;ISSN: 1432-0428 ;EISSN: 1432-0428 ;DOI: 10.1007/s00125-019-4889-y ;PMID: 31089754

Full text available

11
On the causal relationships between hyperinsulinaemia, insulin resistance, obesity and dysglycaemia in type 2 diabetes: Reply to Johnson JD [letter]
Material Type:
Article
Add to My Research

On the causal relationships between hyperinsulinaemia, insulin resistance, obesity and dysglycaemia in type 2 diabetes: Reply to Johnson JD [letter]

Diabetologia, 2021-10, Vol.64 (10), p.2345-2347 [Peer Reviewed Journal]

This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply 2021 ;This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply 2021. ;ISSN: 0012-186X ;ISSN: 1432-0428 ;EISSN: 1432-0428 ;DOI: 10.1007/s00125-021-05511-6 ;PMID: 34324020

Full text available

12
Acute renal injury events in diabetic patients treated with SGLT2 inhibitors: A comprehensive review with a special reference to RAAS blockers
Material Type:
Article
Add to My Research

Acute renal injury events in diabetic patients treated with SGLT2 inhibitors: A comprehensive review with a special reference to RAAS blockers

Diabetes & metabolism, 2022-03, Vol.48 (2), p.101315-101315, Article 101315 [Peer Reviewed Journal]

2021 Elsevier Masson SAS ;Copyright © 2021 Elsevier Masson SAS. All rights reserved. ;ISSN: 1262-3636 ;ISSN: 1878-1780 ;EISSN: 1878-1780 ;DOI: 10.1016/j.diabet.2021.101315 ;PMID: 34910981

Full text available

13
Low concentration IL-1β promotes islet amyloid formation by increasing hIAPP release from humanised mouse islets in vitro
Material Type:
Article
Add to My Research

Low concentration IL-1β promotes islet amyloid formation by increasing hIAPP release from humanised mouse islets in vitro

Diabetologia, 2020-11, Vol.63 (11), p.2385-2395 [Peer Reviewed Journal]

This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply 2020 ;This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply 2020. ;ISSN: 0012-186X ;ISSN: 1432-0428 ;EISSN: 1432-0428 ;DOI: 10.1007/s00125-020-05232-2 ;PMID: 32728889

Full text available

14
Multivariable Prediction Model for Biochemical Response to First-Generation Somatostatin Receptor Ligands in Acromegaly
Material Type:
Article
Add to My Research

Multivariable Prediction Model for Biochemical Response to First-Generation Somatostatin Receptor Ligands in Acromegaly

The journal of clinical endocrinology and metabolism, 2020-09, Vol.105 (9), p.2964-2974 [Peer Reviewed Journal]

Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2020 ;Copyright © Oxford University Press 2015 ;Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. ;COPYRIGHT 2020 Oxford University Press ;Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com ;ISSN: 0021-972X ;ISSN: 1945-7197 ;EISSN: 1945-7197 ;DOI: 10.1210/clinem/dgaa387 ;PMID: 32589751

Full text available

15
Impact of metformin and Dysosmobacter welbionis on diet-induced obesity and diabetes: from clinical observation to preclinical intervention
Material Type:
Article
Add to My Research

Impact of metformin and Dysosmobacter welbionis on diet-induced obesity and diabetes: from clinical observation to preclinical intervention

Diabetologia, 2024-02, Vol.67 (2), p.333-345 [Peer Reviewed Journal]

The Author(s) 2023 ;ISSN: 0012-186X ;EISSN: 1432-0428 ;DOI: 10.1007/s00125-023-06032-0

Digital Resources/Online E-Resources

16
Mechanisms of the anti-obesity effects of oxytocin in diet-induced obese rats
Material Type:
Article
Add to My Research

Mechanisms of the anti-obesity effects of oxytocin in diet-induced obese rats

PloS one, 2011-09, Vol.6 (9), p.e25565 [Peer Reviewed Journal]

COPYRIGHT 2011 Public Library of Science ;COPYRIGHT 2011 Public Library of Science ;2011 Deblon et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Deblon et al. 2011 ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0025565 ;PMID: 21980491

Full text available

17
Acute Inhibition of Intestinal Neprilysin Enhances Insulin Secretion via GLP-1 Receptor Signaling in Male Mice
Material Type:
Article
Add to My Research

Acute Inhibition of Intestinal Neprilysin Enhances Insulin Secretion via GLP-1 Receptor Signaling in Male Mice

Endocrinology (Philadelphia), 2023-03, Vol.164 (5), p.1 [Peer Reviewed Journal]

The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2023 ;The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. ;COPYRIGHT 2023 Oxford University Press ;The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com ;ISSN: 1945-7170 ;ISSN: 0013-7227 ;EISSN: 1945-7170 ;DOI: 10.1210/endocr/bqad055 ;PMID: 36964914

Full text available

18
Glucose-lowering agents and risk of ventricular arrhythmias and sudden cardiac death: A comprehensive review ranging from sulphonylureas to SGLT2 inhibitors
Material Type:
Article
Add to My Research

Glucose-lowering agents and risk of ventricular arrhythmias and sudden cardiac death: A comprehensive review ranging from sulphonylureas to SGLT2 inhibitors

Diabetes & metabolism, 2022-11, Vol.48 (6), p.101405, Article 101405 [Peer Reviewed Journal]

2022 Elsevier Masson SAS ;ISSN: 1262-3636 ;ISSN: 1878-1780 ;EISSN: 1878-1780 ;DOI: 10.1016/j.diabet.2022.101405 ;PMID: 36334794

Full text available

19
Neprilysin inhibition improves intravenous but not oral glucose-mediated insulin secretion via GLP-1R signaling in mice with β -cell dysfunction
Material Type:
Article
Add to My Research

Neprilysin inhibition improves intravenous but not oral glucose-mediated insulin secretion via GLP-1R signaling in mice with β -cell dysfunction

American journal of physiology: endocrinology and metabolism, 2022-03, Vol.322 (3), p.E307-E318 [Peer Reviewed Journal]

Copyright American Physiological Society Mar 2022 ;Published by the American Physiological Society. ;ISSN: 0193-1849 ;ISSN: 1522-1555 ;EISSN: 1522-1555 ;DOI: 10.1152/ajpendo.00234.2021 ;PMID: 35128957

Full text available

20
GLP-1 receptor agonists and heart failure in diabetes
Material Type:
Article
Add to My Research

GLP-1 receptor agonists and heart failure in diabetes

Diabetes & metabolism, 2017-04, Vol.43, p.2S13-2S19 [Peer Reviewed Journal]

Elsevier Masson SAS ;2017 Elsevier Masson SAS ;2017 Elsevier Masson SAS. All rights reserved. ;ISSN: 1262-3636 ;ISSN: 1878-1780 ;EISSN: 1878-1780 ;DOI: 10.1016/S1262-3636(17)30068-X ;PMID: 28431666

Full text available

Results 1 - 20 of 134  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (126)

Refine My Results

Creation Date 

From To
  1. Before 2000  (5)
  2. 2000 To 2008  (10)
  3. 2009 To 2012  (24)
  4. 2013 To 2017  (32)
  5. After 2017  (64)
  6. More options open sub menu

Resource Type 

  1. Articles  (72)
  2. Web Resources  (62)
  3. More options open sub menu

Language 

  1. English  (77)
  2. French  (57)
  3. Japanese  (4)
  4. More options open sub menu

Searching Remote Databases, Please Wait